Performance of percutaneous core biopsy in predicting renal tumour pathology: a systematic review
- 21 November 2025
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 138 (S2)
Abstract
Objectives: To systematically assess the diagnostic accuracy of renal tumour core biopsy for detecting malignancy in adults with localised renal masses. Materials and Methods: A search of the Cochrane, Embase and Medline databases and the grey literature published up to September 2024 was performed using pre‐published methods. Eligible studies were published in English, reported all true‐ and false‐positive and ‐negative results for localised renal tumour core biopsies in unique adult cohorts, and used surgical histology as the reference standard. Studies were excluded if they exclusively reported patients with malignant biopsy or surgical histology. Primary outcomes were biopsy sensitivity and specificity for detecting malignancy. Results: Twenty‐one non‐randomised cohorts were identified, totalling 1735 unique patients. In detecting malignancy, renal tumour core biopsy had a weighted mean sensitivity of 98% (95% confidence interval [CI] 0.96–1.00) and specificity of 94% (95% CI 0.84–1.00). Secondary outcomes were determined, including mean false‐positive rate (6%), false‐negative rate (2%), non‐diagnostic rate on first (8%) and second biopsy attempt (9%), and concordance of tumour sub‐type (92%) and Fuhrmann grade, both exact grade (60%) and simplified low/high grade (79%). Summary receiver‐operating characteristic curve analysis demonstrated high test accuracy (area under the curve 0.97). Risk of bias was moderate to high for most studies. Conclusion: Core biopsy for renal masses in adults has high specificity and sensitivity. Excluding patients for whom biopsy will not change management, near‐routine renal tumour biopsy may reduce rates of nephrectomy for ultimately benign tumours, and optimise operating theatre utilisation.Keywords
This publication has 73 references indexed in Scilit:
- Renal Cell CarcinomaJAMA, 2024
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2024
- Concordance between renal tumour biopsy and robotic-assisted partial and radical nephrectomy histology: a 10-year experienceJournal of Robotic Surgery, 2024
- Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta‐analysis of diagnostic test accuracy dataResearch Synthesis Methods, 2020
- Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United StatesEuropean Urology Oncology, 2019
- Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014JAMA Surgery, 2019
- Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significanceAbdominal Radiology, 2017
- The accuracy of renal tumor biopsy: analysis from a national prospective studyWorld Journal of Urology, 2014
- Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancerMedical Oncology, 2014
- Solid renal masses in adults: Image‐guided fine‐needle aspiration cytology and imaging techniques—“Two Heads Better Than One?”Diagnostic Cytopathology, 2007